BackHumacyte Overview

Humacyte Net Tangible Assets

Track Humacyte's net tangible assets ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$31.26M
671.50% YoYΔ $27.21M vs prior year quarter

Peer trimmed avg / median

Loading

Humacyte Net Tangible Assets History

Loading

Humacyte vs. peers: Net Tangible Assets Comparison

Loading

Humacyte Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Humacyte (HUMA) FAQ

As of the most recent data (June 2026), HUMA shows a net tangible assets of $31M. That compares with $4.1M in the prior-year period — up 671.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HUMA's net tangible assets is now $31M (was $4.1M) — a 671.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Humacyte is outperforming or lagging.

Tracking HUMA's net tangible assets over time shows whether Humacyte is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $4.1M in the prior-year period — up 671.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Humacyte's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $31M) with ownership activity and broader fundamentals.

Humacyte's net tangible assets is $31M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.